High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies.

J Mol Med. 1996 Aug;74(8):471-7. Unique Identifier : AIDSLINE MED/97026683
Mine H; Kawai H; Yokoi K; Akaike M; Saito S; First Department of Internal Medicine, School of Medicine,; University of Tokushima, Japan.


Abstract: To investigate the relationship between human T-lymphotropic virus (HTLV) types I and II and the pathogenesis of autoimmune thyroid diseases, we examined serum anti-thyroid antibodies in 1019 blood donors with or without serum anti-HTLV-I antibody as well as proviral DNA for HTLV-II in leukocyte DNA by the polymerase chain reaction in 395 blood donors with or without anti-thyroid antibodies. The frequency of donors with anti-HTLV-I antibody who also showed anti-thyroid antibodies (7.9%) tended to be higher than that (6.3%) among donors who did not have the anti-HTLV-I antibody. The frequency of anti-thyroid antibodies in 125 young male donors aged 16-39 years with anti-HTLV-I antibody (4.8%) was significantly higher (P < 0.05) than that (0.6%) in 164 control donors without the antibody. In blood donors with anti-thyroid antibody, 25.0% of those with anti-HTLV-I antibody and 14.3% of those without the antibody had HTLV-II proviral DNA. In contrast, in donors without anti-thyroid antibody HTLV-II proviral DNA was detected in 2.3% of those with anti-HTLV-I antibody and in 0.6% of those without the antibody. Thus the detection rates in donors with anti-thyroid antibody were significantly higher (P < 0.001) than those in donors without the antibody, regardless of HTLV-I infection. These results suggest that HTLV-I infection and the presence of HTLV-II proviral DNA may be independently related to the pathogenesis of autoimmune thyroid diseases.
Keywords: Adolescence Adult Aged Antibodies/*BLOOD Blood Donors/STATISTICS & NUMER DATA DNA Primers DNA, Viral/ANALYSIS/BLOOD Electrophoresis, Polyacrylamide Gel Female Genes, pol/GENETICS Genes, pX/GENETICS Human HTLV-I/*IMMUNOLOGY/METABOLISM HTLV-II/*IMMUNOLOGY/METABOLISM Japan Leukocytes/CHEMISTRY Male Middle Age Polymerase Chain Reaction Proviruses/GENETICS Retroviridae/GENETICS/IMMUNOLOGY Serology Support, Non-U.S. Gov't Thyroid Gland/*IMMUNOLOGY JOURNAL ARTICLEKWDadolescenceadultagedantibodies/KWDbloodblooddonors/statistics&numerdatadnaprimersdna,viral/analysis/bloodelectrophoresis,polyacrylamidegelfemalegenes,pol/geneticsgenes,px/geneticshumanhtlv-i/KWDimmunology/metabolismhtlv-ii/KWDimmunology/metabolismjapanleukocytes/chemistrymalemiddleagepolymerasechainreactionproviruses/geneticsretroviridae/genetics/immunologyserologysupport,non-uKWDsKWDgov'tthyroidgland/KWDimmunologyjournalarticle
970228
M9721929

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .